Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
Annals of Internal Medicine|April 1, 1983
Small-cell carcinoma of lung: reinduction therapy after late relapseG Batist, D C Ihde, A Zabell, et al.Biochemical Pharmacology|October 11, 1996
Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetateL Panasci, B J Jean-Claude, D Vasilescu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
SarCNU, a nitrosourea analog on a day 1, 5, and 9 oral schedule: a phase I and pharmacokinetic study in patients with advanced solid tumorsL Panasci, S F Stinson, D Melnychuk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B studyR C Lilenbaum, A A Miller, G Batist, et al.American Journal of Clinical Oncology|August 1, 1990
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicityE Dmitrovsky, E J Seifter, A F Gazdar, et al.Lung|October 8, 2005
Phase II study of troxacitabine (BCH-4556) in patients with advanced non-small-cell lung cancerS F Dent, A Arnold, D J Stewart, et al.Archives of Internal Medicine|May 1, 1985
Ultrasonography and computed tomography in severe urinary tract infectionC H June, M D Browning, L P Smith, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 20, 2010
Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paperM Aapro, C Bernard-Marty, E G C Brain, et al.Current Oncology (Toronto, Ont.)|October 25, 2013
Benefits, issues, and recommendations for personalized medicine in oncology in CanadaC Butts, S Kamel-Reid, G Batist, et al.Investigational New Drugs|January 1, 1985
Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusionG Batist, R W Klecker, H N Jayaram, et al.Pageof 12